Company intelligence / Profile preview

Ecoplan

Bern, Switzerland

Ownership: Private
Development stage: Other

Overview

Ecoplan is a Swiss economic and policy consulting and research firm, not a biotech, pharma, or healthcare operating company. The firm provides analysis and advisory services across themes including economy, society, education, transport, energy and environment, and also health and ageing policy. Based on the available evidence, Ecoplan does not develop therapeutic products, drug candidates, or healthcare technologies, and it does not appear to operate a life sciences pipeline. It is therefore best classified as a non-health consulting company that may work on health policy topics rather than a life science or biotech enterprise.

Industry: Consulting

Beyond the preview

Go deeper on Ecoplan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ecoplan.

Explore the full profile